Test and Training Enabling Architecture

Magentrix Partner Management Platform Joins the HubSpot App Marketplace

Retrieved on:

Tuesday, November 29, 2022

Software, Marketing, Growth, PEM, App, Platform as a service, Test and Training Enabling Architecture, CRM, PRM, Ecosystem, HubSpot, Online shopping, Food delivery, Sales

TORONTO, Nov. 29, 2022 /PRNewswire-PRWeb/ -- Today, Magentrix PRM announced that it is now a HubSpot app partner. App Partners are independent software vendors who have built an integration with HubSpot and been accepted to the App Marketplace.

Key Points:

TORONTO, Nov. 29, 2022 /PRNewswire-PRWeb/ -- Today, Magentrix PRM announced that it is now a HubSpot app partner.
App Partners are independent software vendors who have built an integration with HubSpot and been accepted to the App Marketplace .
Vendors utilizing HubSpot as their CRM, can leverage the Magentrix integration for managing and growing their partner ecosystems, with a multitude of tools for partner ecosystem management (PEM) and partner relationship management (PRM).
Ability to leverage HubSpot CRM data to fuel the Magentrix PRM automations, forms, segmentation and other partner management features.

Pharmacovigilance Outsourcing Market Size to Reach $9.65 Bn, Globally, by 2030 at 14.6% CAGR: Allied Market Research

Retrieved on:

Wednesday, August 25, 2021

Knowledge, Industry, CAGR, Service, Risk management, Pharmaceutical industry, Growth, Adoption, Business, Coronavirus, Test and Training Enabling Architecture, Research, Disulfiram-like drug, Knowledge management, Deference, ADR, Contract, Pharmacovigilance, Fine chemical

According to the report, the pharmacovigilance outsourcing industry generated $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030, registering a CAGR of 14.6% from 2021 to 2030.

Key Points:

According to the report, the pharmacovigilance outsourcing industry generated $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030, registering a CAGR of 14.6% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11280
Rise in preference for outsourcing services and increase in in adverse drug reactions and drug toxicity drive the growth of the global pharmacovigilance outsourcing market.
Which in turn, led to increased demand for pharmacovigilance outsourcing, owing to surge in incidences of adverse drug reactions.
This is due to strict regulations for reporting adverse drug reactions coupled with large number of companies offering pharmacovigilance outsourcing services across the region.

Pharmacovigilance Outsourcing Market Size to Reach $9.65 Bn, Globally, by 2030 at 14.6% CAGR: Allied Market Research

Retrieved on:

Wednesday, August 25, 2021

PORTLAND, Ore., Aug. 25, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Pharmacovigilance Outsourcing Market by Type (Adverse Drug Reaction Capture (ADR), Case Processing, Reporting and Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, and Enabling Architecture), Service Provider (Contract Research Organizations and Business Processing Outsourcing), and End User (Pharmaceutical Industry, Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the pharmacovigilance outsourcing industry generated $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030, registering a CAGR of 14.6% from 2021 to 2030.

Key Points:

Rise in preference for outsourcing services and increase in adverse drug reactions and drug toxicity drive the growth of the global pharmacovigilance outsourcing market.
According to the report, the pharmacovigilance outsourcing industry generated $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030, registering a CAGR of 14.6% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11280
Rise in preference for outsourcing services and increase in in adverse drug reactions and drug toxicity drive the growth of the global pharmacovigilance outsourcing market.
This is due to strict regulations for reporting adverse drug reactions coupled with large number of companies offering pharmacovigilance outsourcing services across the region.